{"id":8528,"date":"2026-02-26T16:01:07","date_gmt":"2026-02-26T16:01:07","guid":{"rendered":"https:\/\/www.vanguardlifesciences.co.uk\/?post_type=case-study&p=8528"},"modified":"2026-02-26T16:24:29","modified_gmt":"2026-02-26T16:24:29","slug":"cell-and-gene-therapy","status":"publish","type":"case-study","link":"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/case-study\/cell-and-gene-therapy\/","title":{"rendered":"Unit\u00e9 cl\u00e9 de th\u00e9rapie cellulaire et g\u00e9nique au Royaume-Uni, Enbloc a r\u00e9alis\u00e9 l'am\u00e9nagement complet en conception et construction."},"content":{"rendered":"
\"\"<\/figure>\n

Ce nouveau b\u00e2timent offre au Client des installations modernes, flexibles et bien con\u00e7ues, comprenant des salles blanches et des laboratoires, des vestiaires et des espaces de travail de bureaux, reli\u00e9es au b\u00e2timent actuel du site NHS BT \u00e0 Bristol.<\/p>\n

En bloc<\/a> Nous avons enti\u00e8rement r\u00e9alis\u00e9 la conception, la construction et l'am\u00e9nagement, en collaboration avec le client, afin de cr\u00e9er des salles de confinement propres contr\u00f4l\u00e9es et classifi\u00e9es au premier \u00e9tage, avec des laboratoires de soutien et des bureaux au rez-de-chauss\u00e9e.<\/p>\n

Enbloc continue de travailler avec NHS BT dans le cadre d'un contrat de validation et de maintenance permanent pour ce site.<\/p>\n

\"\"<\/figure>\n
\"\"<\/figure>\n
\"\"<\/figure>\n
\"\"<\/figure>","protected":false},"excerpt":{"rendered":"

Enbloc a \u00e9t\u00e9 s\u00e9lectionn\u00e9 comme entrepreneur cl\u00e9 en main pour la conception et la construction du nouveau centre d'extension de biotechnologie clinique du NHS BT \u00e0 Filton.<\/p>","protected":false},"author":18,"featured_media":8568,"template":"","format":"standard","case-study-category":[],"case-study-topic":[],"class_list":["post-8528","case-study","type-case-study","status-publish","format-standard","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nCell and Gene Therapy Key CGT unit in the UK, Enbloc carried out complete D&B fitout - Vanguard Life Sciences<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/case-study\/cell-and-gene-therapy\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cell and Gene Therapy Key CGT unit in the UK, Enbloc carried out complete D&B fitout - Vanguard Life Sciences\" \/>\n<meta property=\"og:description\" content=\"Enbloc were selected as the Design and Build turnkey Contractor to provide the new Clinical Biotechnology Centre Expansion Facility at the NHS BT in Filton\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/case-study\/cell-and-gene-therapy\/\" \/>\n<meta property=\"og:site_name\" content=\"Vanguard Life Sciences\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-26T16:24:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/02\/1-4.png\" \/>\n\t<meta property=\"og:image:width\" content=\"795\" \/>\n\t<meta property=\"og:image:height\" content=\"577\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/case-study\\\/cell-and-gene-therapy\\\/\",\"url\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/case-study\\\/cell-and-gene-therapy\\\/\",\"name\":\"Cell and Gene Therapy Key CGT unit in the UK, Enbloc carried out complete D&B fitout - Vanguard Life Sciences\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/case-study\\\/cell-and-gene-therapy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/case-study\\\/cell-and-gene-therapy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2026\\\/02\\\/1-4.png\",\"datePublished\":\"2026-02-26T16:01:07+00:00\",\"dateModified\":\"2026-02-26T16:24:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/case-study\\\/cell-and-gene-therapy\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/case-study\\\/cell-and-gene-therapy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/case-study\\\/cell-and-gene-therapy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2026\\\/02\\\/1-4.png\",\"contentUrl\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2026\\\/02\\\/1-4.png\",\"width\":795,\"height\":577},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/case-study\\\/cell-and-gene-therapy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cell and Gene Therapy Key CGT unit in the UK, Enbloc carried out complete D&B fitout\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/#website\",\"url\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/\",\"name\":\"Vanguard Life Sciences\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cell and Gene Therapy Key CGT unit in the UK, Enbloc carried out complete D&B fitout - Vanguard Life Sciences","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/case-study\/cell-and-gene-therapy\/","og_locale":"fr_FR","og_type":"article","og_title":"Cell and Gene Therapy Key CGT unit in the UK, Enbloc carried out complete D&B fitout - Vanguard Life Sciences","og_description":"Enbloc were selected as the Design and Build turnkey Contractor to provide the new Clinical Biotechnology Centre Expansion Facility at the NHS BT in Filton","og_url":"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/case-study\/cell-and-gene-therapy\/","og_site_name":"Vanguard Life Sciences","article_modified_time":"2026-02-26T16:24:29+00:00","og_image":[{"width":795,"height":577,"url":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/02\/1-4.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.vanguardlifesciences.co.uk\/case-study\/cell-and-gene-therapy\/","url":"https:\/\/www.vanguardlifesciences.co.uk\/case-study\/cell-and-gene-therapy\/","name":"Cell and Gene Therapy Key CGT unit in the UK, Enbloc carried out complete D&B fitout - Vanguard Life Sciences","isPartOf":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/case-study\/cell-and-gene-therapy\/#primaryimage"},"image":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/case-study\/cell-and-gene-therapy\/#primaryimage"},"thumbnailUrl":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/02\/1-4.png","datePublished":"2026-02-26T16:01:07+00:00","dateModified":"2026-02-26T16:24:29+00:00","breadcrumb":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/case-study\/cell-and-gene-therapy\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vanguardlifesciences.co.uk\/case-study\/cell-and-gene-therapy\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.vanguardlifesciences.co.uk\/case-study\/cell-and-gene-therapy\/#primaryimage","url":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/02\/1-4.png","contentUrl":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/02\/1-4.png","width":795,"height":577},{"@type":"BreadcrumbList","@id":"https:\/\/www.vanguardlifesciences.co.uk\/case-study\/cell-and-gene-therapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.vanguardlifesciences.co.uk\/"},{"@type":"ListItem","position":2,"name":"Cell and Gene Therapy Key CGT unit in the UK, Enbloc carried out complete D&B fitout"}]},{"@type":"WebSite","@id":"https:\/\/www.vanguardlifesciences.co.uk\/#website","url":"https:\/\/www.vanguardlifesciences.co.uk\/","name":"Vanguard Sciences de la vie","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vanguardlifesciences.co.uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/wp-json\/wp\/v2\/case-study\/8528","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/wp-json\/wp\/v2\/case-study"}],"about":[{"href":"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/wp-json\/wp\/v2\/types\/case-study"}],"author":[{"embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/wp-json\/wp\/v2\/users\/18"}],"version-history":[{"count":0,"href":"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/wp-json\/wp\/v2\/case-study\/8528\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/wp-json\/wp\/v2\/media\/8568"}],"wp:attachment":[{"href":"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/wp-json\/wp\/v2\/media?parent=8528"}],"wp:term":[{"taxonomy":"case-study-category","embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/wp-json\/wp\/v2\/case-study-category?post=8528"},{"taxonomy":"case-study-topic","embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/wp-json\/wp\/v2\/case-study-topic?post=8528"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}